Business Wire

iCareDx Announces Appointment Of Advisory Board

Del

iCareDx, Inc., a biotechnology company focused on blood-based early detection of cancer, today announced the formation of an Advisory Board, comprised of renowned scientists, clinicians and business leaders in the areas of oncology and diagnostics. The Advisory Board’s role will be to provide valuable scientific, clinical and business insights, along with strategic guidance in decision-making, as the Company seeks to advance its blood-based screening tests for early detection of colorectal cancer as well as for early detection in pan-oncology.

“We are honored to welcome such outstanding authorities in their respective areas to our advisory board to support the development of iCareDx's early detection screening technologies,” said Dr. Bernard Peperstraete, the Chief Executive Officer of iCareDx. “In forming the company’s inaugural Advisory Board, we are seeking to further position iCareDx to successfully pursue a highly accurate and cost-effective approach for early cancer detection, and to ultimately help reduce cancer deaths.”

Over the past years, the design of iCareDx's molecular detection technologies was led by Francis Barany, PhD, Professor of Microbiology and Immunology at the Weill Cornell Medicine. Dr. Barany is a prolific inventor with 52 issued US patents, which are foundational inventions in molecular diagnostics and next generation sequencing, and include the ligase chain reaction (LCR), the ligase detection reaction (LDR), and the Universal DNA array. “We have assembled this team of thought leaders to guide our efforts in advancing our platform for blood-based early cancer detection,” said Dr. Francis Barany. “Our scalable, low-cost cancer detection platforms are designed to vastly improve cancer care, ultimately throughout the world.”

Composition of iCareDx's Advisory Board:

  • Mr. Haywood Cochrane. Previously, CEO at CHD Meridian Corp (now part of Walgreens), at Allied Clinical Labs and at Take Care Employer Solutions; EVP, CFO and Treasurer at LabCorp, COO at Biomedical Reference Labs, SVP North-America Diagnostics and COO at Roche Biomedical labs; Director at Tripath Imaging, American Esoteric Labs, Sonus Corp., Ameripath, Unilab Corp.
  • Dr. Paolo Fortina. Professor of Cancer Biology and Medical Oncology at the Sidney Kimmel Medical College, Director of the NCI-designated Cancer Genomics Laboratory at the Sidney Kimmel Cancer Center, Thomas Jefferson University.
  • Dr. David Gelfand. Previously, Vice President, Discovery Research Division and Director for the Program in Core Research at Roche Molecular Systems, CSO of WaferGen BioSystems, and a consultant at the Centre National de Génotypage in France, inventor of the real-time PCR (“TaqMan”) technology and many thermostable DNA Polymerases and Reverse Transcriptases.
  • Dr. Larry J. Kricka. Professor of Pathology & Laboratory Medicine at the University of Pennsylvania Director of the General Chemistry and Endocrinology Laboratory at the Hospital of the University of Pennsylvania.
  • Dr. Christopher Mason. Associate Professor Computational Genomics at Weill Cornell Medicine, with appointments at Department of Physiology and Biophysics, Institute for Computational Biomedicine, Meyer Cancer Center, Feil Family Brain and Mind Research Institute. WorldQuant Foundation Research Scholar. Affiliate Fellow of Genomics, Ethics, and Law, ISP, Yale Law School.
  • Dr. Kenneth Offit. Chief of Clinical Genetics Service at Memorial Sloan-Kettering Cancer Center, Member of the Program in Cancer Biology and Genetics at the Sloan-Kettering Institute, Professor of Medicine and Public Health at the Weill Cornell Medicine.
  • Dr. Mark Pochapin. Sholtz/Leeds Professor, Director of Gastroenterology, Professor of Medicine at NYU Langone Medical Center. Advanced gastrointestinal endoscopy, and the prevention, early detection, and treatment of gastrointestinal cancers.

About iCareDx Inc.

iCareDx is a biotechnology company focused on developing technologies for blood-based early detection of cancer. iCareDx's technology allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable. Backed by a highly experienced team, it is iCareDx’s mission to contribute to the global battle against cancer by detecting and attacking cancer through high-precision, early detection.

For more information, please visit www.icaredx.com, or contact us at info@icaredx.com.

Contact information

iCareDx, Inc.
Bernard Peperstraete
Chief Executive Officer
info@icaredx.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Düsseldorf Airport to Deploy Next Generation ECAC Standard 3 EDS Screening Technology from Smiths Detection24.1.2018 09:00Pressemelding

Smiths Detection is supplying next generation hold baggage scanners to support the upgrade to ECAC Standard 3 explosives detection systems (EDS) at Düsseldorf Airport. Awarded by the Procurement Office of the German Ministry of Interior, the contract includes 14 advanced HI-SCAN 10080 XCT scanners, which deliver exceptional levels of security; and can be further updated as necessary in the future to detect new explosive threats. There is also an associated eight year service agreement. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180124005070/en/ Düsseldorf Airport to deploy next generation ECAC Standard 3 EDS screening technology from Smiths Detection (Photo: Business Wire) “European airports are currently very focused on upgrading to ECAC Standard 3 approved EDS to meet the new regulations,” commented Tony Tielen VP EMEA, Smiths Detection. “This does, of course, require a financial investment which must be clearly weighed

GleSYS Tap Into Telia Carrier Backbone to Increase Capacity and Support Growth Plans24.1.2018 09:00Pressemelding

Telia Carrier announced today that it is working with one of Sweden’s fastest growing hosting companies, GleSYS , to provide improved capacity and support future growth plans. GleSYS will be connecting to the Telia Carrier global backbone, one of the largest in the world, and the first to be 100G enabled in Europe and North America. GleSYS provides hosting and data centre services to over 4,000 customers in 70 countries. With two fully redundant datacentres in Sweden and a network of cloud hosting locations, GleSYS supports a range of industries, such as eCommerce, where performance, responsiveness and reliability on a global scale have a direct impact on revenues and are therefore critical. Telia Carrier will be providing 100G IP Transport and wavelength network transport services to double available capacity on GleSYS’ current infrastructure, which provides cloud hosting, dedicated servers and colocation in multiple sites across Europe. Eric Lindsjö, Head of Networks at GleSYS, said;

GSMA Announces Nominees for 2018 GLOMO Awards24.1.2018 09:00Pressemelding

The GSMA today announced the nominees for the Global Mobile Awards 2018 (GLOMO Awards). Winners of the awards will be presented throughout Mobile World Congress, which takes place 26 February – 1 March in Barcelona. The full list of nominees can be found at http://gsma.at/glomoshortlist. "The GLOMOs offer organisations and individuals from across the world an opportunity to showcase how mobile technology continues to inspire new levels of ingenuity, innovation and achievement,” said Michael O’Hara, Chief Marketing Officer, GSMA. “As always, the calibre of entries is extremely high, so to be shortlisted for the GLOMOs today is quite an achievement in itself. We wish the very best of luck to all nominees and look forward to unveiling the winners at Mobile World Congress next month.” The GLOMO Awards feature an afternoon ceremony at 15:30 CET on Tuesday, 27 February in Auditorium 5, Hall 4, and will include the presentation of winners in three categories including “Social Good”, “Governme

Integral Expands Cryptocurrency Market Data Services to Include 14 Cryptocurrencies and 16 Exchanges23.1.2018 22:00Pressemelding

Integral (www.integral.com), the financial technology partner trusted by leading banks, brokers, and investment managers to design, deliver and grow their FX businesses, announced today that it has expanded its market data offering for cryptocurrencies to include 14 major cryptocurrencies connecting to all major exchange sources across the U.S., Europe and Asia including Japan and Hong Kong. “An accurate, stable, and reliable reference price is a requirement for any market maker,” said Harpal Sandhu, CEO of Integral. “The Cryptocurrency Market Data Service connects to the most price sources and applies the most advanced price discovery algorithm available.” Integral has years of experience as a technology leader and innovator in foreign exchange and is now applying this ingenuity to the cryptocurrency market. The Market Data Service uses algorithms developed with Stanford University for Integral FX Benchmark to provide the most precise reference prices for cryptocurrencies. “Integral’s

Kimbal Riley to Become Vista Group CEO23.1.2018 21:57Pressemelding

Vista Group International (NZX & ASX: VGL) has today announced that Kimbal Riley will take over as Group CEO from Murray Holdaway. Mr Holdaway will take up the position of Chief Product Officer (CPO) for Vista Group, and will continue in his role as an Executive Director on the Vista Group board. This has taken place as part of a succession planning process and will deliver a seamless transition within the business. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180123006545/en/ Kimbal Riley becomes CEO of Vista Group International (Photo: Business Wire) Mr Riley has had an extensive career in senior executive roles in the IT and Services industries in New Zealand and overseas. He joined Vista Group four years ago, with the past two years as CEO of Vista Entertainment Solutions (VES), which is responsible for the largest proportion of the Group’s revenue. He has been focused on building scale in the business and under his lea

IFF Breaks Ground on Flavors/Fragrances Site in Sri City, India23.1.2018 17:00Pressemelding

Regulatory News: International Flavors & Fragrances Inc. (NYSE: IFF) (Euronext Paris: IFF), a leading innovator of sensory experiences that move the world, has broken ground on a new flavors and fragrances plant located in Sri City, in the State of Andhra Pradesh in India. Part of a larger investment into the Greater Asia region, the plant is expected to be commercialized in December 2019. The new facility, which will be the largest flavor and fragrance manufacturing facility in India and the largest IFF site in Greater Asia, occupies a 32-acre/130,000m2 plot and will serve IFF flavors and fragrances customers across India and the region. “In this economically vibrant country, it is critical that we invest to provide our customers with winning tastes and scents,” said IFF Chairman and CEO Andreas Fibig. “This new facility is fitted with capabilities tailored for our customers’ needs. Coupled with our excellent consumer insights teams and their deep understanding of the local markets, w

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom